Home/Filings/4/0001209191-21-033999
4//SEC Filing

Trainer John 4

Accession 0001209191-21-033999

CIK 0001538210other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:16 PM ET

Size

10.6 KB

Accession

0001209191-21-033999

Insider Transaction Report

Form 4
Period: 2021-04-08
Trainer John
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-04-083,432113,245 total
    Exercise: $5.17Exp: 2030-03-04Common Stock (3,432 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-05-083,432109,813 total
    Exercise: $5.17Exp: 2030-03-04Common Stock (3,432 underlying)
  • Exercise/Conversion

    Common Stock

    2021-05-08$5.17/sh+3,432$17,74354,906 total
  • Exercise/Conversion

    Common Stock

    2021-04-08$5.17/sh+3,432$17,74351,474 total
Footnotes (1)
  • [F1]This option vests as to 25% of the shares on January 8, 2021 with the remainder vesting in equal installments every month thereafter, beginning on January 8, 2021 and ending on January 8, 2024.

Issuer

NexImmune, Inc.

CIK 0001538210

Entity typeother

Related Parties

1
  • filerCIK 0001843820

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:16 PM ET
Size
10.6 KB